This paper aimed to improve in vitro dissolution/solubility as well as inhibit intestinal
metabolism and thus enhance oral bioavailability for a BDDCS class II drug by constructing …

The potential applications of dendrimer-like biopolymers (DLB) as stabilizing excipients for
amorphous solid dispersion (ASD) of niclosamide, celecoxib, and resveratrol were …

Drug delivery of poorly soluble drugs in form amorphous solid dispersions (ASDs) is an
appealing method to increase in vivo bioavailability. For rational formulation design, a …

The current study aimed to investigate drug carrier miscibility in pharmaceutical solid
dispersions (SD) and include the effervescent system, ie Effervescence-induced amorphous …

In this study, the performance of phase separated and crystallized amorphous solid
dispersions (ASDs) was evaluated by non-sink in vitro dissolution testing in fasted-state …

Resveratrol (RES) is a biopharmaceutical classification system (BCS) class II compound
with low solubility and high permeability. Several strategies have been explored to …

The amorphous solid dispersion (ASD) technique has been employed to formulate poorly-
soluble drugs, however, development of solid dosage forms with ASD is challenging due to …

Two widely applied enabling drug delivery approaches, self-nanoemulsifying drug delivery
systems (SNEDDS) and amorphous solid dispersions (ASD), were combined, with the aim of …

Enteric polymers are widely used in amorphous solid dispersion (ASD) formulations. The
aim of the current study was to explore ASD failure mechanisms across a wide range of pH …

Amorphous solid dispersion stands out among different formulation strategies for the
improvement of dissolution rate and bioavailability via generating supersaturated drug …